New clinical trial registered for Dulaglutide

Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease (NCT07537088) registered on ClinicalTrials.gov. Phase: phase 4. Status: not yet recruiting.